Biopharmaceutical Amarin Corp. plc today is reporting positive, statistically significant top-line results from its first Phase 3 clinical trial of lead drug candidate AMR101, which is being investigated as a treatment for very high triglycerides.
(University of Rochester Medical Center) Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics.
Cambridge biofuels company Joule Unlimited Inc. has appointed Eric d’Esparbes as chief financial officer and Kevin Madden as vice president of biology operations at the firm.
EMD Serono's Cladribine Tablets, its drug candidate for treating Multiple Sclerosis, has been given an extension of three months in its FDA review period for treating relapsing MS.
Reason for Recall: It is possible the pump door may not be closed when the latch is down and the pump door open alarm may not alert the user to this condition. This may result in a free flow condition which may result in over delivery of therapy and...
Alternative strategies for controlling imaging utilization, radiology benefit managers and computerized decision support, squared off in a scientific session Sunday.
South Korean LED maker Seoul Semiconductor Corp has announced an agreement with Singapore-based venture capital firm Vertex Venture Management to jointly seek and invest in companies with advanced capabilities in LED technology development.
Designed for defense and security applications, array achieves sensitivity close to one-thousandth of a degree kelvin.
Acceleron Pharma Inc. has appointed Kevin McLaughlin, a former finance head of cellulosic ethanol company Qteros Inc., as senior vice president and chief financial officer of the Cambridge biotechnology firm.
This guidance recommends changes in the labeling of blood lancet (e.g., fingerstick) devices (21 CFR 878.4800) (included under manual surgical instruments for general use). FDA is concerned about the risk of transmission of hepatitis and other...
Federal Register: Guidance for Industry and Food and Drug Administration Staff; Blood Lancet Labeling; AvailabilityNovember 29, 2010 4:38 am | by U.S. Food & Drug Administration | Comments
FDA is issuing this guidance with labeling recommendations because of concerns that both healthcare providers and patients may be unaware of the serious adverse health risks associated with using the same blood lancet device for assisted withdrawal of...
PositiveID Corporation Expands Its Wireless Body Platform Utilizing Its Patented Embedded Bio-Sensor SystemNovember 29, 2010 4:33 am | by PositiveID | Comments
PositiveID Corporation Expands Its Wireless Body Platform Utilizing Its Patented Embedded Bio-Sensor System
Managed care company UnitedHealth Group Inc. said Monday it expects a drop in earnings per share next year compared to its 2010 projections, despite an anticipated revenue increase.The Minnetonka, Minn., health insurer forecasts 2011 net earnings of $3.50 to $3.70 per share, down from its...
SET makes strides to enable 3D Integration with high precision Chip-to-Chip and Chip-to-Wafer bondingNovember 29, 2010 12:40 am | by I-Micronews | Comments
SET collaborates with CEA-LETI, STMicroelectronics, ALES and the CEMES-CNRS on advanced chipto-wafer technologies (direct metallic bonding) for 3D integration.
(Radiological Society of North America) Using a mobile MRI unit, researchers followed runners for two months along a 4,500-kilometer course to study how their bodies responded to the high-stress conditions of an ultra-long-distance race, according to a new study.